Patents by Inventor Massimo Guidoboni

Massimo Guidoboni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Idiotypic vaccine
    Patent number: 8512703
    Abstract: The invention concerns the use of recombinant clonotypic immunoglobulins (Ig) as a vaccine in the treatment of HCV-related and non HCV-related lymphoproliferations, in particular the use of recombinant proteins with immunogenic properties derived from protein segments VK3-20 and VK3-15 of Ig light chains derived from patients with lymphoproliferations.
    Type: Grant
    Filed: July 24, 2008
    Date of Patent: August 20, 2013
    Assignee: Areta International S.R.L.
    Inventors: Riccardo Dolcetti, Massimo Guidoboni, Valli De Re, Daniela Gasparotto, Sonia Castiglioni, Maria Luisa Nolli
  • IDIOTYPIC VACCINE
    Publication number: 20100310586
    Abstract: The invention concerns the use of recombinant clonotypic immunoglobulins (Ig) as a vaccine in the treatment of HCV-related and non HCV-related lymphoproliferations, in particular the use of recombinant proteins with immunogenic properties derived from protein segments VK3-20 and VK3-15 of Ig light chains derived from patients with lymphoproliferations.
    Type: Application
    Filed: July 24, 2008
    Publication date: December 9, 2010
    Applicant: ARETA INTERNATIONAL S.r.l
    Inventors: Riccardo Dolcetti, Massimo Guidoboni, Valli De Re, Daniela Gasparotto, Sonia Castiglioni, Maria Luisa Nolli